T7645 |
[Des-Arg9]-Bradykinin
|
15958-92-6
|
98%
|
|
[Des-Arg9]-Bradykinin(2TFA) is an agonist of Bradykinin (B1) receptor.
|
T33421 |
MK-0686
|
1159193-97-1
|
98%
|
|
MK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity.
|
T8809 |
[Des-Arg9]-Bradykinin TFA
|
199433-70-0
|
98%
|
|
[Des-Arg9]-Bradykinin is an agonist of Bradykinin (B1) receptor that displays selectivity for B1 over B2 receptors.
|
T21610 |
Bradykinin (acetate)
|
6846-03-3
|
98%
|
|
Bradykinin (acetate) is an active peptide that is generated by the kallikrein-kinin system. It is a inflammatory mediator and also recognized as a neuromediator ...
|
TP1277 |
Bradykinin
|
58-82-2
|
98%
|
|
Bradykinin is an inflammatory mediator. It is a peptide that causes blood vessels to dilate (enlarge) via the release of prostacyclin, nitric oxide, and Endothel...
|
TP1181 |
Bradykinin (2-9)
|
16875-11-9
|
98%
|
|
Bradykinin (2-9) is an amino-truncated peptide compound that is a metabolite of Bradykinin. It is formed by the cleavage action of Aminopeptidase P.
|
TP1933 |
R715 TFA(185052-09-9 free base)
|
TP1933
|
98%
|
|
Potent and selective bradykinin B1 receptor antagonist (pA2 = 8.49). Displays no activity at B2 receptors. Reduces mechanical hypernociception in a mouse model o...
|
TP1918L |
Lys-[Des-Arg9]Bradykinin,TFA
|
TP1918L
|
98%
|
|
Lys-[Des-Arg9]Bradykinin,TFA is Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 recep...
|
T21060L |
NPC 567 acetate
|
T21060L
|
98%
|
|
NPC 567 acetate is a bradykinin B2 antagonist and can be used in studies about the treatment of allergic airway disease.
|
T22344 |
Icatibant Acetate
|
138614-30-9
|
98%
|
|
Icatibant Acetate, an antagonist of the bradykinin B2 receptor, is used in the treatment of hereditary angioedema.
|
T72070 |
Acetamide, 2-[[7-[(3-bromophenyl)methyl]-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]thio]-
|
326918-98-3
|
98%
|
|
Acetamide, 2-[[7-[(3-bromophenyl)methyl]-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]thio]- is a BRAF inhibitor.
|
T2086 |
ELN-441958
|
913064-47-8
|
98%
|
|
ELN-441958 is a potent, neutral antagonist of B1 receptor, inhibits the binding of the B1 agonist ligand [3H]DAKD to IMR-90 cells with Ki of 0.26 nM. ELN-441958 ...
|
TP1445 |
[Des-Arg9]-Bradykinin acetate
|
23827-91-0
|
98%
|
|
[Des-Arg9]-Bradykinin acetate is a selective agonist of Bradykinin B1 receptor.
|
T5048 |
SSR240612
|
464930-42-5
|
98%
|
|
SSR240612 is a potent, and orally active specific non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.73 and 358-481 nM for B1 and B2 receptors, respecti...
|
T36442L |
(Hyp³)-Bradykinin acetate
|
T36442L
|
98%
|
|
(Hyp³)-Bradykinin acetate is an agonist of bradykinin B2 receptor and stimulates inositol phosphate production in cultured human fibroblasts.
|
T28222 |
5-Hydroxy-1-methylhydantoin
|
84210-26-4
|
98%
|
|
NZ-419 is an antioxidant potentially for the treatment of renal failure. A creatinine metabolite, NZ-419, a hydroxyl radical scavenger, has previously been shown...
|
T34485 |
Safotibant
|
633698-99-4
|
98%
|
|
Safotibant is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
|
T26627L |
Anatibant 2HCl
|
209788-45-4
|
98%
|
|
Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury.
|
TP2268L |
Lys-Bradykinin acetate(342-10-9 free base)
|
84640-50-6
|
98%
|
|
Lys-Bradykinin acetate is an endogenous bradykinin receptor agonist.
|
TP1918L1 |
Lys-[Des-Arg9]Bradykinin acetate
|
TP1918L1
|
98%
|
|
Lys-[Des-Arg9]Bradykinin acetate is an endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B...
|